Author

C. Dore

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:multiome· 1

Frequent Co-Authors

J. Yockell-Lelievre· 2 shared W. L. Stanford· 2 shared A. Camacho-Magallanes· 1 shared A. Pietrobon· 1 shared A. S. Kristof· 1 shared C. Choey· 1 shared C. Xue· 1 shared D. J. Stewart· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

J. Yockell-Lelievre

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Three-dimensional drug screen identifies HDAC inhibitors as therapeutic agents in mTORC1-driven lymphangioleiomyomatosis

A. Pietrobon, J. Yockell-Lelievre, N. Melong, L. J. Smith, S. P. Delaney, N. Azzam, C. Xue, N. Merwin, E. Lian, A. Camacho-Magallanes, C. Dore, G. Musso, L. M. Julian, A. S. Kristof, R. Y. Tam, , W. L. Stanford

A 3D drug screen identified HDAC inhibitors as effective against mTORC1-driven lymphangioleiomyomatosis by reducing invasion and selectively killing TSC2-/- cells.

bioRxiv · Jul 3, 2021Cell Biology

Transcriptomically-guided mesendoderm induction of human pluripotent stem cells using a systematically defined culture scheme

R. L. Carpenedo, S. Y. Kwon, R. M. Tanner, J. Yockell-Lelievre, C. Choey, C. Dore, M. Ho, D. J. Stewart, T. J. Perkins, W. L. Stanford

This study introduces a method using single-cell seeding and BMP4/Activin A treatment to induce mesendoderm from hPSCs, showing increased mesoderm and endoderm formation.

bioRxiv · Feb 26, 2019Bioengineering